Reseach into the effects of sitagliptin on blood sugar control in patients with type2 diabetes
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPIRITS-J
- 03 Mar 2017 Status changed from active, no longer recruiting to completed.
- 28 Aug 2012 Planned end date 31 Mar 2015 added as reported by University Hospital Medical Information Network - Japan record.
- 29 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.